BIOSBioSenic S.A.
0.0020EUR0.00%Mkt Cap: 1.42M $P/E:

BioSenic S.A., a biotechnology company, develops cell therapy products and treatments for autoimmune and inflammatory diseases in Belgium and France. The company offers arsenic trioxide (ATO) and oral arsenic trioxide (O…

Key Statistics

Company
Market Cap1.42M $
Enterprise Value26.45M $
Revenue (TTM)-2.59M $
Gross Profit-2.59M $
Net Income (TTM)-31.28M $
Revenue/Share-0.0065 USD
Last Price0.0020 EUR
Fiscal Year EndDec 2024
MR QuarterJun 2025
Employees7
CountryBE
SectorHealthcare
IndustryBiotechnology
ISINBE0974280126
Valuation
P/E (Trailing)
P/E (Forward)-0.04
PEG
EV/EBITDA-5.06
EV/Revenue-10.19
P/S-0.55
P/B-0.06
EPS (TTM)-0.02
EPS (Forward)-0.05
52W Range
0.001820% of range0.0028
52W High0.0028 EUR
52W Low0.0018 EUR
Profitability
Gross Margin0.00%
Oper. Margin-70700.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE125.60%
ROA-301.06%
Growth
Revenue Growth-100.00%
Earnings Growth
Cash Flow & Leverage
Operating CF-3.77M $
CapEx (TTM)
FCF Margin145.17%
FCF Yield-265.38%
Net Debt25.03M $
Net Debt/EBITDA-4.79
Balance Sheet
Debt/Equity-1.23
Current Ratio0.53
Quick Ratio0.50
Book Value/Sh-0.0360 EUR
Cash/Share0.0010 EUR
Dividends
Fwd Div Rate
Trail. Div Rate0.0000 EUR
Div. Yield
5Y Avg Yield
Payout Ratio0.00%
Ex-Div Date
Pay Date
Analyst Consensus
Rating
Target (Mean)
Target Range
# Analysts
Ownership
Shares Out.652.86M
Float603.17M
Insiders14.14%
Institutions0.00%
Technical
SMA 500.0020 (+0.0%)
SMA 2000.0022 (-9.7%)
Beta-1.60
S&P 52W Chg18.16%
Avg Vol (30d)0
Avg Vol (10d)0
Technical Indicators
RSI (14)39.4
MACD-0.0000
MACD Signal-0.0000
MACD Hist.+0.0000
BB Upper0.0020 EUR
BB Middle0.0020 EUR
BB Lower0.0020 EUR
BB Width0.00%
ATR (14)0.0000 EUR
Vol Ratio (20d)